YOLFTbeta
Imexhs Ltd

Imexhs Ltd

IME · AU · Healthcare / Diagnostics & Research

0.33AUD+0.00 (0.00%)

Price History

Full chart

Market Stats

Previous Close0.33
Open0.33
Day Range0.33 – 0.33
52-Week Range0.23 – 0.47
Volume4.38K
Market Cap17.68M
P/E (TTM)32.50
Forward P/E0.00
EPS0.01
Dividend Yield0.00%
Beta0.81
50-Day Avg0.3195
200-Day Avg0.3668

About

ImExHS Limited offers cloud-based medical imaging solutions in Australia and internationally. The company operates in two segments: Software and Radiology. It offers medical imaging software that is focused on the development and sale of modular imaging systems, which include information systems for radiology, cardiology, and pathology, as well as a picture archiving and communications system. The company's solutions include AQUILA, a radiology software solution; ALULA, a pathology software solution; and ANTEROS, a cardiology software solution. It also provides radiological diagnostic services to hospitals and medical facilities; medical images and radiologists' interpretation; reports to develop artificial intelligence (AI) tools; and outsourced radiology services, as well as teleradiology services. ImExHS Limited was incorporated in 2001 and is based in Sydney, Australia.

Company Details

  • SectorHealthcare
  • IndustryDiagnostics & Research
  • CEODr. German Arango
  • Employees290
  • Headquarters32 Martin Place, Sydney, NSW, Australia, 2020, Australia
  • Websitehttps://www.imexhs.com

Leadership

  • Dr. German ArangoCo-Founder, CEO, MD & Executive Director
  • Dr. Jorge H-Marin MunozCo-Founder & Chief Medical Officer
  • Mr. Andres VanegasCo-Founder & Strategic Accounts Manager
  • Mr. Alexander SanzCo-Founder
  • Mr. Fabio CarrilloChief Financial Officer
  • Mr. Orlando JovenChief Operating Officer
  • Mr. Juan David FajardoVP of Global Sales
  • Mr. Benjamin BrinquisHead of Growth
  • Ms. Kamille DietrichCompany Secretary

Financials

Income Statement

Currency: AUD2004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue142.00K4.31M18.17M6.37M5.07M12.03M-----91.02K80.12K3.55M5.78M7.74M10.91M13.37M17.12M19.67M26.57M28.97M
Growth (%)-+2932.39%+321.95%-64.92%-20.54%+137.47%-------11.98%+4326.03%+63.00%+33.84%+41.08%+22.53%+28.00%+14.91%+35.08%+9.04%
Cost of Revenue57.00K2.05M17.71M7.66M2.93M4.70M-64.00K61.80K18.14K-6.42K1.77M2.90M3.40M5.04M6.46M8.20M13.60M16.17M15.54M20.66M
Gross Profit-2.26M460.00K-1.29M2.13M8.04M------2.22M-1.69M648.80K2.38M2.70M2.70M5.22M3.52M3.50M11.03M8.31M
Gross Margin-52.48%2.53%-20.18%42.05%66.80%------2443.78%-2109.41%18.30%41.14%34.86%24.74%39.06%20.56%17.78%41.50%28.69%
Operating Expense-3.05M14.43M10.80M3.73M5.48M------1.15M2.29M1.24M3.55M7.92M5.01M8.37M5.94M6.20M11.39M9.01M
Operating Income--791.00K-13.97M-12.09M-1.60M2.55M-56.99K-444.92K-514.85K-219.68K-144.99K-1.08M-3.98M-592.00K-1.17M-5.22M-2.31M-3.14M-2.42M-2.70M-367.11K-697.64K
Operating Margin--18.37%-76.91%-189.60%-31.55%21.21%------1182.21%-4962.74%-16.69%-20.22%-67.50%-21.14%-23.50%-14.16%-13.72%-1.38%-2.41%
EBITDA--569.00K-13.02M-21.41M-1.23M-21.59M230.56K721.34K-479.61K-190.26K-144.99K-1.07M-4.45M-581.00K-3.96M-4.32M-1.30M-3.00M-744.21K-1.26M45.58K1.52M
EBITDA Margin--13.21%-71.64%-335.85%-24.19%-179.52%------1175.15%-5559.37%-16.38%-68.53%-55.80%-11.95%-22.46%-4.35%-6.40%0.17%5.25%
Net Income--681.00K-13.90M-29.50M-2.00M-24.93M-344.55K691.24K-492.61K-190.27K-121.91K-2.85M-4.49M68.47K-4.89M-6.00M-3.62M-4.70M-3.04M-4.19M-2.63M-2.88M
Net Income Margin--15.82%-76.49%-462.80%-39.41%-207.29%------3130.42%-5605.55%1.93%-84.55%-77.59%-33.13%-35.15%-17.75%-21.31%-9.88%-9.95%
R&D197.00K267.00K-919.00K143.00K------6.18K280.72K19.54K1.34M2.12M646.66K1.11M1.53M2.44M2.92M2.26M
R&D as % of Total Revenue138.73%6.20%-14.42%2.82%------6.79%350.39%0.55%23.18%27.42%5.93%8.34%8.92%12.40%11.01%7.80%
Interest Expense028.00K52.00K427.00K24.00K43.06K051110000528.13K899.52K1.21M311.09K442.69K332.14K468.86K375.05K
Interest Expense % of Total Revenue0.00%0.65%0.29%6.70%0.47%0.36%-----0.00%0.00%0.00%9.14%11.63%11.04%2.33%2.59%1.69%1.76%1.29%

Balance Sheet

Currency: AUD2004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets2.47M23.51M35.06M13.20M9.87M4.38K7001.28M753.21K835.95K1.22M4.55M496.05K1.55M9.26M14.80M20.80M25.01M20.99M22.65M21.81M23.73M
Total Liabilities1.23M2.76M9.84M2.65M1.17M1.89M1.85M100.42K50.01K30.81K43.21K380.20K822.15K89.09K3.41M4.48M5.27M8.36M5.09M6.67M7.33M7.86M
Total Equity1.24M20.75M25.23M10.56M8.70M-1.88M-1.85M1.18M703.21K805.14K1.18M4.17M-326.10K1.46M5.85M10.32M15.54M16.65M15.90M15.98M14.47M15.87M
Cash1.27M12.15M234.00K377.00K332.00K1.40M-1.26M675.45K799.68K666.54K3.66M187.74K963.96K2.45M7.15M10.80M4.19M1.91M2.36M2.07M3.30M
Total Debt-589.00K3.43M97.00K213.00K1.32K------250.00K457.39K188.49K2.10M1.70M2.40M1.12M1.29M1.19M566.32K
Net Debt-589.00K3.19M-280.00K-119.00K-1.40M--1.26M-675.45K-799.68K-666.54K-3.66M62.26K-506.57K-2.26M-5.05M-9.10M-1.79M-794.80K-1.07M-882.73K-2.73M

Cash Flow

Currency: AUD2004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow---11.65M-10.88M-2.24M-2.66M-84.50K-1.16M-584.70K-167.97K-129.34K-1.01M-3.65M-109.86K-1.54M-4.09M-1.47M-2.97M-2.20M2.61M-634.68K564.71K
Investing Cash Flow---20.10M-1.91M2.08M1.94M-287.56K-11.78K---500.00K-192.82K-29.71K-696.43K-1.32M-2.46M-2.19M-3.39M-2.22M-2.13M-765.91K-1.19M
Financing Cash Flow3.17M20.10M18.23M14.54M114.00K481.00K373.38K2.43M-292.20K496.21K4.50M244.40K1.47M5.26M11.28M7.40M-161.78K2.25M-98.61K1.18M1.68M
Capital Expenditure710.00K2.74M20.13M2.72M667.00K1.78M00000622.65K29.71K370.49K1.32M2.30M2.19M2.56M2.03M2.20M1.06M320.55K
Free Cash Flow---31.77M-13.60M-2.90M-4.43M-84.50K-1.16M-584.70K-167.97K-129.34K-1.63M-3.68M-480.35K-2.86M-6.39M-3.65M-5.53M-4.23M414.59K-1.69M244.16K
Dividends Paid---------------2.38M6.93M101.89K1.97M---
FCF to OCF--272.81%124.98%129.80%166.83%100.00%100.00%100.00%100.00%100.00%161.88%100.81%437.23%185.52%156.31%249.03%186.41%192.39%15.89%266.90%43.24%
Dividend Paid to FCF----------------37.28%-189.56%-1.84%-46.57%---

Earnings

Report DateMar 31, 2016Apr 1, 2016Aug 31, 2016Apr 3, 2017Aug 30, 2017Feb 28, 2018Jul 30, 2018Feb 28, 2019Aug 27, 2019Feb 27, 2020Aug 31, 2020Feb 25, 2021Aug 30, 2021Dec 1, 2021Feb 28, 2022May 18, 2022Aug 30, 2022Oct 31, 2022Feb 28, 2023Apr 28, 2023Aug 31, 2023Oct 30, 2023Feb 28, 2024May 29, 2024Aug 29, 2024Nov 27, 2024Mar 30, 2025Apr 30, 2025Aug 28, 2025Nov 3, 2025
EPS Estimate0.000.000.000.000.000.000.000.000.000.000.000.00-0.000.000.00-0.00-0.000.000.000.000.000.000.000.000.00-0.00
EPS Actual-0.08-0.08-0.11-0.09-0.010.000.00-0.010.000.000.00-0.05-0.090.00-0.060.00-0.050.00-0.030.000.000.000.000.000.000.00-0.020.00-0.060.00
Surprise------------------------------
Timing--------------Pre-market-Pre-marketPre-marketPre-marketAfter-hoursAfter-hoursPre-market------Pre-market-

Key Statistics & Ratios

Market Cap17.68M
Enterprise Value15.60M
Trailing P/E32.50
Forward P/E0.00
Price / Sales0.57
Price / Book1.00
EPS0.01
Book Value0.317
Revenue (TTM)31.27M
Gross Profit (TTM)14.97M
EBITDA523.92K
Profit Margin0.60%
Operating Margin0.86%
Return on Equity1.19%
Return on Assets0.51%
Shares Outstanding54.40M
Shares Float26.00M
Beta0.81
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Stock Splits

  • Aug 5, 2022909:904
  • Nov 4, 20201:50
  • Jun 2, 20171:10
  • Jun 2, 20151:20
  • Apr 21, 20111:3
  • Mar 31, 20091:10
  • May 2, 200720:11